gamma-glutamylaminomethylsulfonic acid has been researched along with ergoline in 1 studies
Studies (gamma-glutamylaminomethylsulfonic acid) | Trials (gamma-glutamylaminomethylsulfonic acid) | Recent Studies (post-2010) (gamma-glutamylaminomethylsulfonic acid) | Studies (ergoline) | Trials (ergoline) | Recent Studies (post-2010) (ergoline) |
---|---|---|---|---|---|
52 | 0 | 2 | 4,324 | 381 | 441 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaddis, FG; Uretsky, NJ; Wallace, LJ | 1 |
1 other study(ies) available for gamma-glutamylaminomethylsulfonic acid and ergoline
Article | Year |
---|---|
AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cocaine; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Glutamine; Injections; Kainic Acid; Male; Motor Activity; Nerve Endings; Nucleus Accumbens; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid | 1993 |